These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Aktas B, Yilmaz Y, Eren F, Yonal O, Kurt R, Alahdab YO, Celikel CA, Ozdogan O, Imeryuz N, Kalayci C, Avsar E. Metabolism; 2011 Apr; 60(4):544-9. PubMed ID: 20580037 [Abstract] [Full Text] [Related]
6. [Correlation of serum omentin-1 and chemerin with gestational diabetes mellitus]. Pan BL, Ma RM. Nan Fang Yi Ke Da Xue Xue Bao; 2016 Aug 20; 36(9):1231-1236. PubMed ID: 27687656 [Abstract] [Full Text] [Related]
7. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. El-Mesallamy HO, El-Derany MO, Hamdy NM. Diabet Med; 2011 Oct 20; 28(10):1194-200. PubMed ID: 21668495 [Abstract] [Full Text] [Related]
9. Relationship of circulating chemerin and omentin levels with Th17 and Th9 cell immune responses in patients with asthma. Zhou Q, Fu Y, Hu L, Li Q, Jin M, Jiang E. J Asthma; 2018 Jun 20; 55(6):579-587. PubMed ID: 28771382 [Abstract] [Full Text] [Related]
11. Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer AA. J Clin Endocrinol Metab; 2013 Mar 20; 98(3):E514-7. PubMed ID: 23303213 [Abstract] [Full Text] [Related]
12. Serum chemerin and vaspin in non-alcoholic fatty liver disease. Kukla M, Zwirska-Korczala K, Hartleb M, Waluga M, Chwist A, Kajor M, Ciupinska-Kajor M, Berdowska A, Wozniak-Grygiel E, Buldak R. Scand J Gastroenterol; 2010 Mar 20; 45(2):235-42. PubMed ID: 20095887 [Abstract] [Full Text] [Related]
13. Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease. Waluga M, Kukla M, Zorniak M, Kajor M, Liszka L, Dyaczynski M, Kowalski G, Zadlo D, Waluga E, Olczyk P, Buldak RJ, Berdowska A, Hartleb M. J Physiol Pharmacol; 2017 Jun 20; 68(3):363-374. PubMed ID: 28820393 [Abstract] [Full Text] [Related]
14. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Guzel EC, Celik C, Abali R, Kucukyalcin V, Celik E, Guzel M, Yilmaz M. Gynecol Endocrinol; 2014 Jun 20; 30(6):419-22. PubMed ID: 24524360 [Abstract] [Full Text] [Related]
15. Serum levels of chemerin, apelin, vaspin, and omentin-1 in obese type 2 diabetic Egyptian patients with coronary artery stenosis. Motawi TMK, Mahdy SG, El-Sawalhi MM, Ali EN, El-Telbany RFA. Can J Physiol Pharmacol; 2018 Jan 20; 96(1):38-44. PubMed ID: 28957639 [Abstract] [Full Text] [Related]
16. Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes. Kukla M, Menżyk T, Dembiński M, Winiarski M, Garlicki A, Bociąga-Jasik M, Skonieczna M, Hudy D, Maziarz B, Kusnierz-Cabala B, Skladany L, Grgurevic I, Wójcik-Bugajska M, Grodzicki T, Stygar D, Rogula T. Sci Rep; 2021 Nov 02; 11(1):21514. PubMed ID: 34728695 [Abstract] [Full Text] [Related]
18. Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease. Ye Z, Wang S, Yang Z, He M, Zhang S, Zhang W, Wen J, Li Q, Huang Y, Wang X, Lu B, Zhang Z, Su Q, Hu R. Mol Biol Rep; 2014 Mar 02; 41(3):1317-23. PubMed ID: 24390241 [Abstract] [Full Text] [Related]
19. The Association between Circulating Adipocytokine Omentin Levels and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Khodashahi R, Aliakbarian M, Ferns GA, Arjmand MH. Curr Mol Med; 2024 Mar 02; 24(11):1374-1381. PubMed ID: 37711002 [Abstract] [Full Text] [Related]
20. Circulating apelin, chemerin and omentin levels in patients with gestational diabetes mellitus: a systematic review and meta-analysis. Sun J, Ren J, Zuo C, Deng D, Pan F, Chen R, Zhu J, Chen C, Ye S. Lipids Health Dis; 2020 Feb 22; 19(1):26. PubMed ID: 32087711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]